Vanina Alzogaray

869 total citations
9 papers, 649 citations indexed

About

Vanina Alzogaray is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Vanina Alzogaray has authored 9 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Vanina Alzogaray's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Vanina Alzogaray is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Vanina Alzogaray collaborates with scholars based in Argentina, Germany and United States. Vanina Alzogaray's co-authors include Fernando A. Goldbaum, Friedrich Koch‐Nolte, Friedrich Haag, Ana Cauerhff, Nicole Schwarz, Felix Scheuplein, Jan Reyelt, Mariela Urrutia, Michel Séman and Mandy Unger and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Vanina Alzogaray

9 papers receiving 634 citations

Peers

Vanina Alzogaray
Jan Reyelt Germany
Mandy Unger Germany
Mariela Urrutia Argentina
Sara D’Angelo United States
Agnes E. Hamburger United States
Barry Kriegsman United States
Letitia A. Wims United States
Tae Hyun Kang South Korea
Vanina Alzogaray
Citations per year, relative to Vanina Alzogaray Vanina Alzogaray (= 1×) peers Welbeck Danquah

Countries citing papers authored by Vanina Alzogaray

Since Specialization
Citations

This map shows the geographic impact of Vanina Alzogaray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanina Alzogaray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanina Alzogaray more than expected).

Fields of papers citing papers by Vanina Alzogaray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanina Alzogaray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanina Alzogaray. The network helps show where Vanina Alzogaray may publish in the future.

Co-authorship network of co-authors of Vanina Alzogaray

This figure shows the co-authorship network connecting the top 25 collaborators of Vanina Alzogaray. A scholar is included among the top collaborators of Vanina Alzogaray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanina Alzogaray. Vanina Alzogaray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lakshmi, S., Vanina Alzogaray, Sara Nathan, et al.. (2022). Development of high-affinity nanobodies specific for NaV1.4 and NaV1.5 voltage-gated sodium channel isoforms. Journal of Biological Chemistry. 298(4). 101763–101763. 8 indexed citations
2.
Alzogaray, Vanina, Mariela Urrutia, Paula M. Berguer, et al.. (2019). Characterization of folding-sensitive nanobodies as tools to study the expression and quality of protein particle immunogens. Journal of Biotechnology. 293. 17–23. 1 indexed citations
3.
Unger, Mandy, Anna Marei Eichhoff, Stephan Menzel, et al.. (2015). Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT. Scientific Reports. 5(1). 7850–7850. 54 indexed citations
4.
Berguer, Paula M., et al.. (2012). A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants. PLoS ONE. 7(9). e45705–e45705. 14 indexed citations
5.
Craig, Patricio O., Vanina Alzogaray, & Fernando A. Goldbaum. (2012). Polymeric Display of Proteins through High Affinity Leucine Zipper Peptide Adaptors. Biomacromolecules. 13(4). 1112–1121. 15 indexed citations
6.
Alzogaray, Vanina, Welbeck Danquah, Andrés Aguirre, et al.. (2010). Single‐domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP‐ribosylating toxin of Salmonella typhimurium. The FASEB Journal. 25(2). 526–534. 32 indexed citations
7.
Urrutia, Mariela, et al.. (2009). Single Domain Antibodies Are Specially Suited for Quantitative Determination of Gliadins under Denaturing Conditions. Journal of Agricultural and Food Chemistry. 58(2). 918–926. 27 indexed citations
8.
Wesolowski, Janusz, Vanina Alzogaray, Jan Reyelt, et al.. (2009). Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Medical Microbiology and Immunology. 198(3). 157–174. 406 indexed citations
9.
Koch‐Nolte, Friedrich, Jan Reyelt, Nicole Schwarz, et al.. (2007). Single domain antibodies from llama effectively and specifically block T cell ecto‐ADP‐ribosyltransferase ART2.2 in vivo. The FASEB Journal. 21(13). 3490–3498. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026